pharmaceuticals
pharmaceuticals Articles
Spectrum Pharmaceuticals on Thursday after the firm announced that it would be selling its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma.
Published:
Last Updated:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Loxo shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly. The transaction is not subject to any financing condition and is expected to close by...
Published:
Last Updated:
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the first quarter of 2019.
Published:
Last Updated:
Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen for its treatment of secondary hyperparathyroidism in adult patients with chronic...
Published:
Last Updated:
Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene shareholders are scheduled to receive a 54% premium to Wednesday...
Published:
Last Updated:
Merck shares were relatively unchanged early on Thursday after the firm announced that its blockbuster drug Keytruda reported a series of approvals in Japan.
Published:
Last Updated:
Spectrum Pharma shares dipped on Thursday after the firm announced a key update from the FDA on its treatment of neutropenia in breast cancer patients.
Published:
Last Updated:
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Published:
Last Updated:
GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will create a premier global consumer health care company combining...
Published:
Last Updated:
Eli Lilly shares were slightly lower after the company announced positive results from its late-stage active psoriatic arthritis study.
Published:
Last Updated:
Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby powder sometimes contained the known carcinogen asbestos.
Published:
Last Updated:
Eli Lilly shares rose slightly on Thursday after the company announced an FDA update on its treatment for systemic lupus erythematosus.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated: